A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus (Q37378350)
scientific article published on September 2009
Language:
(P31) (Q13442814)
(P50) (Q67485110)
(Q67485131)
(Q91640182)
(P304) 1168-1178
(P433) 9
(P478) 61
(P577) Tuesday, September 1, 2009
(P921) (Q269829)
(Q181600)
(Q1485)
(Q1996249)
(P1433) (Q4797636)
(P1476) "A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus" (language: en)
(P2093) Daniel J Wallace
William Stohl
Richard A Furie
Jeffrey R Lisse
James D McKay
W Winn Chatham
W Joseph McCune
Vivian Fernandez
Marc R Chevrier
Z John Zhong
William W Freimuth
(P2860) (Q37356378)
(Q36926846)
(Q36993242)
(Q34802966)
(Q28263864)
(Q33960050)
(Q34895937)
(Q35968394)
(Q28587037)
(Q28183674)
(Q35140484)
(Q27639845)
(Q34108411)
(Q28190857)
(Q33951524)
(Q33928629)
(Q36368953)
(Q22254448)
(Q22254041)
(Q35110335)
(Q36375661)
(Q28139180)
(Q29614922)
(Q40419059)
(Q40724809)
(Q52884043)
(Q46825742)
(Q46851436)
(Q46851432)
(Q46557882)
(Q47913418)
(Q43050637)
(Q53566418)
(Q73198904)
(Q84643349)
(Q82732869)
(Q79318119)
(Q73537551)
(Q74419758)
other details
description scientific article published on September 2009

External Links